Brought to you by 
Litha acquires South African products and drug candidates from Aspen
30 Jan 2023
Executive Summary
For $130mm, Aspen Pharmacare Holdings Ltd. sold a group of its branded and generic injectable products marketed in South Africa, as well as drug candidates, to Litha Healthcare Group Ltd. (majority owned by Endo International PLC's Paladin Labs Inc.).
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- Generic Drugs
Deal Status
- Final
Deal Type
-
Alliance
- Includes Equity
- Product Purchase
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Litha acquires South African products and drug candidates from Aspen
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice